QualityStocksNewsBreaks Archives - Page 574 of 1477

ThursdayDec 02, 2021 10:01 am

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Receives Green Light from FDA for Clinical Study in Fibromyalgia

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, today announced its receipt of confirmation from the U.S. Food and Drug Administration (“FDA”) that its review of Tryp’s Investigational New Drug (“IND”) application is complete and that the company may proceed with its clinical study in fibromyalgia. The trial, which the company expects to initiate in 2022, is being conducted with Kevin Boehnke, Ph.D. from the University of Michigan and will evaluate Tryp’s oral formulation of synthetic psilocybin, TRP-8802, in combination with psychotherapy. “The upcoming phase 2a study with…

ThursdayDec 02, 2021 9:25 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Participation in Future of Healthcare Conference

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), will be presenting in the upcoming Stifel GMP second annual Future of Healthcare Conference. The conference, which is slated for Dec. 8, 2021, will include a presentation by Cybin CEO Doug Drysdale. According to the announcement, Drysdale’s presentation is scheduled to start at 3:30 p.m. ET. Following the presentation, interested viewers can view an archived version of the webcast on Cybin’s investor relations website. Cybin is working to create safe and effective therapeutics for patients to address a multitude of mental health issues. To view the…

WednesdayDec 01, 2021 2:51 pm

QualityStocksNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Reimagining Mental Health, Addiction Treatment

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, recently filed a patent application covering bioavailability-enhancing, nanoemulsion-empowered formulations. The move followed on the heels of a previous announcement that the company had filed a final patent application for MYCO-003, one of its lead drug candidates. Nanoemulsion is an advanced drug delivery system that offers enhanced stability, fast digestibility, controlled release and protection against degradation. “Specifically, Mydecine is targeting the enhanced bioavailability and controlled capabilities of the nanoemulsion technology. The system’s controlled-release capability, for example, will…

WednesdayDec 01, 2021 2:43 pm

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Providing Artists, Fans the Best that Music Offers

Friendable (OTC: FDBL), a mobile technology and marketing company, released Fan Pass in July 2020 as a platform for artists to share their work and fans to get a front-row seat to the action from the comfort of their home. Since then, the platform has grown considerably. “During the latter part of 2021, the company’s main focus has been to make the Fan Pass platform more visible and accessible. Now, the company is focusing on moving into 2022, offering artists and fans the best that music offers,” reads a recent article. “Artists who sign up with the Fan Pass platform…

WednesdayDec 01, 2021 2:40 pm

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Eager to Initiate ‘One of the First Evaluations of Psilocybin to Treat Fibromyalgia’

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) recently submitted an Investigational New Drug (“IND”) application to the U.S. FDA to evaluate its TRP-8802 clinical candidate in a phase 2a clinical trial to explore psilocybin-assisted therapy’s safety and preliminary effectiveness among individuals dealing with fibromyalgia. The study, which is being conducted in collaboration with the University of Michigan, spearheaded by Kevin Boehnke, Ph.D., will involve 20 fibromyalgia patients and include various exploratory endpoints, particularly given the high prevalence of comorbidities that include anxiety, depression, poor sleep quality and other conditions. Tryp expects to initiate the study in 2022, subject to a favorable…

WednesdayDec 01, 2021 2:00 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) to Deconsolidate BIGtoken Inc. (FPVD) Following Merger

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, has announced that, from this date forward, it will no longer have to consolidate the financials of BIGtoken (OTC: FPVD). On Sept. 27, 2021, BIGtoken, the leading platform for ethically-sourced identity, data and insights creation and media activation, and BritePool Inc., a leading identity verification company for advertisers and publishers, entered into an agreement and plan of merger in an all-stock transaction. Upon completion of the union, SRAX is no longer obligated to consolidate BIGtoken into its financials.…

WednesdayDec 01, 2021 10:48 am

QualityStocksNewsBreaks – LQwD Fintech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Featured in Latest Episode of ‘Bell2Bell’ Podcast

LQwD Fintech (TSX.V: LQWD) (OTCQB: LQWDF), a financial technology company focused on creating enterprise-grade infrastructure to drive bitcoin adoption, was featured in the “Bell2Bell Podcast,” a part of IBN’s (“InvestorBrandNetwork”) sustained effort to provide specialized content distribution via widespread syndication channels. LQwD’s co-founder, chairman and CEO Shone Anstey joined the latest episode to discuss LQwD’s business model and his proven track record in the fast-moving cryptocurrency sector. “We are known as a Lightning Network service provider, or a liquidity service provider. We have a platform-as-a-service, which you can look up on our website. There, you can go in and create a Lightning Network node…

WednesdayDec 01, 2021 10:06 am

QualityStocksNewsBreaks – Lottery.com (NASDAQ: LTRY) Names New Global VP of Affiliate Success

Lottery.com (NASDAQ: LTRY, LTRYW), a leading technology company that is transforming how, where and when the lottery is played, has appointed marketing veteran Greg Potts as its new global vice president of affiliate success. With more than two decades of strategic marketing experience, Potts has developed growth strategies for numerous consumer brands through targeted marketing efforts using co-op funding mechanisms. In his new position with Lottery.com, he will oversee the company’s business-to-business (“B2B”) growth strategy as well as its new Global Affiliate Marketing Program, which aims to add master affiliates and sub-affiliates while providing them with tools to accelerate the…

TuesdayNov 30, 2021 3:11 pm

QualityStocksNewsBreaks – Tingo Inc. (IWBB) Ranking Amongst Rarest of Companies

Tingo (OTCQB: IWBB) recently applied to list its shares for trading with the New York Stock Exchange (“NYSE”), forming part of efforts to broaden its appeal to U.S. and international investors. Although there are no guarantees that its listing application will be accepted, the company has reiterated its belief that it will satisfy the NYSE’s initial listing criteria. A recent article quotes Tingo CEO Dozy Mmobuosi as saying: “The NYSE is the main stock exchange in the United States and one that will raise our profile to the broader investment community. The bottom-up list will increase liquidity in our stocks…

TuesdayNov 30, 2021 2:06 pm

QualityStocksNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Releases Q3 2021 Report Showing 1,000% Increase in Revenues

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, has released its unaudited financial results for the quarter ended Sept. 30, 2021; all numbers are in Canadian dollars. Among the highlights include a revenue growth figure of $1.1 million, which represents more than a 1,000% increase over the $94,000 reported in the same quarter last year. In addition, the company noted gross profit of $356,168 during Q3 2021, compared to a loss of $40,280 for Q3 2020. BevCanna closed the quarter with cash reserves of $655,563. Business highlights include a…

Site Search

Company Search

Category: QualityStocksNewsBreaks